HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Harper Selected Research

Melanoma (Melanoma, Malignant)

7/2013Melanoma immunotherapy using mature DCs expressing the constitutive proteasome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Harper Research Topics

Disease

1Melanoma (Melanoma, Malignant)
07/2013
1Atrial Fibrillation
08/2002
1Infections
08/2002
1Myocardial Infarction
08/2002

Drug/Important Bio-Agent (IBA)

1Peptides (Polypeptides)IBA
07/2013
1Neoplasm Antigens (Tumor Antigens)IBA
07/2013
1Monophenol Monooxygenase (Tyrosinase)IBA
07/2013
1AntigensIBA
07/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
07/2013
1Melanoma-Specific AntigensIBA
07/2013
1Troponin IIBA
08/2002
1CreatinineIBA
08/2002
1Nonesterified Fatty Acids (NEFA)IBA
08/2002
1glucose-insulin-potassium cardioplegic solutionIBA
08/2002

Therapy/Procedure

1Immunotherapy
07/2013
1Length of Stay
08/2002
1Therapeutics
08/2002